ArticlePharmaceutics2022

Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial.

Luca Cegolon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.